Metatranscriptomic Markers of Colonic Neoplasia

Metatranscriptomic Markers As A Predictor of Colonic Neoplasia at the Time of Colonoscopy

This study is a collaboration between Viome Life Sciences and Scripps Research Institute to develop and validate a noninvasive molecular diagnostic test for the detection of colorectal polyps. Approximately 1,000 participants undergoing colonoscopy will provide saliva and stool samples prior to their procedure. Molecular features identified in these samples will be evaluated in relation to colonoscopy findings to develop a predictive model for colorectal polyp detection. The resulting model will then be evaluated in an independent validation dataset to assess its performance for identifying individuals with colorectal polyps.

Inclusion Criteria:

• Male or female, aged 18 years or older
• Undergoing colonoscopy with bowel preparation
• Able to provide stool and saliva samples prior to colonoscopy
• No stoma present
• No known personal history of colorectal cancer

Exclusion Criteria:

• Individuals under 18 years of age
• Patients with a stoma
• Personal history of colorectal cancer